INTRODUCTION
Malignant small round cell tumors (MSRCT) are a group of highly undifferentiated neoplasm composed of monotonous population of round cells with high nuclear to cytoplasmic ratio. The histological similarity and lack of differentiating features on hematoxylin and eosin (HE) sections in most of them makes definite diagnosis difficult, and requires the additional support of immunohistochemical (IHC) and molecular studies. In 80-90% of cases diagnosis can be made on HE staining slides coupled with IHC. However in 15-20% there is a need for molecular or electron microscopic diagnosis. The (MSRCT) that cause potential diagnostic confusion include Non Hodgkin Lymphoma (NHL), Lymphoblastic Lymphoma (LL), Ewing sarcoma/Primitive Neuroectodermal tumor (ES/PNET), Rhabdomyosarcoma 
The immunostaining was considered positive only if the signal localization is correct for the antibody used.
RESULTS
Out of 40 cases of MSRCT, the most common tumor was NHL (21 cases, 52.5%) followed by Ewing's Sarcoma/ Primitive Neuroectodermal Tumor (11 cases, 27.5%).
Varieties of MSRCT and its location are given in Table 1 and Table 2 .
Each tumor was adequately categorized using the appropriate antibody panel. The recommended immunohistochemical panel for small round cell tumors is summarized in Table-3 .
Immunohistochemical staining was interpreted in the context of morphology in the appropriate cells concerned by comparing with the corresponding HE section.
DISCUSSION
Immunohistochemistry is playing an increasing role in modern surgical pathology. 3, 4 The objective of performing immunohistochemistry (IHC) is to recognize cell constituents (antigens) and, consequently, to identify and classify specific cells within a cell population whose morphology is heterogeneous or apparently homogenous. The visualization of the antigen-antibody complex is made possible through the addition of either a fluorochrome conjugate or an enzyme to the antibody, which is then viewed under microscopy. 5 The use of extensive panels of antibodies in all malignant undifferentiated neoplasm's allows accurate histological diagnosis in more than 89% cases. 6 As shown in our results in Table 2 , NHL in organs other than the lymph nodes is the most common MSRCT. IHC was performed in all cases of suspected NHL. The tumor cells show cytoplasmic and membranous immunoreactivity to CD45 (Fig.1A and 1B) . Cytokeratin (CK) was negative which excluded poorly differentiated and undifferentiated carcinomas. CD45 is a surface antigen expressed by virtually all hematolymphoid proliferations, and monoclonal antibodies for this marker are reliably specific.
7, 8 EWS/PNET is the second most common MSRCT. The tumor cells show cytoplasmic immunoreactivity to vimentin and membranous immunoreactivity to CD99 (Fig  2A and 2B) . CD45 was negative which ruled out lymphoma. Immunohistochemically, strong membrane staining for CD99 is consistently seen in almost all cases of EWS/ PNET, although it is not very specific because it is shown in several other soft tissue sarcomas and lymphoblastic lymphomas. [9] [10] [11] [12] There was one case of LL which showed membrane positivity for CD99 but negative staining for CD45. This excluded the diagnosis of NHL but EWS/ PNET was considered in the differentials. LL is especially a diagnostic challenge because of its overlap with EWS both morphologically and immunohistochemically. 13 LL may be negative for CD45, but positive for CD99. In our study, LL showed negative staining to vimentin hence the possibility of EWS/PNET was eliminated. We found one case of rhabdomyosarcoma which showed cytoplasmic immunoreactivity for vimentin, desmin and CD99, hence subcategorized as alveolar rhabdomyosarcoma. Immunohistochemically, rhabdomyosarcoma express skeletal muscle markers, specifically, desmin, myoD1, myogenin and CD99(the alveolar type).
14,15 It's due to the unavailability of the following markers in our laboratory, There were 2 cases of atypical carcinoid tumor and one case of neuroblastoma which showed cytoplasmic positivity for NSE, synaptophysin and chromogranin. Absence of positive staining for CD99 and CD45 was helpful in differentiating it from EWS/PNET and lymphoma. The markers CD56, synaptophysin, and chromogranin A are restricted to neuroendocrine neoplasms; nevertheless, it should be reemphasized that they are seen in only 30-50% of cases. 16 Neuroblastoma shows immunoreactivity with NSE, synaptophysin, chromogranin-A, CD56, and NB84. Tumor cells usually do not react with vimentin, CD99, actin or desmin. 17 We reported 2 cases of small cell variant of synovial sarcoma which was difficult to distinguish from EWS/PNET. However, small cell SS can be differentiated from EWS/PNET by positive staining for EMA(95-100%) of cases, CK(50%); it may also express CD99. 18 These markers EMA and Ck are conversely negative in most EWS/PNET. [19] [20] [21] [22] In our study the tumor cells labeled for EMA(cytoplasmic), CD99, and vimentin, but CK was negative (Fig 3B-D) . There was one case of malignant melanoma with small cell morphology and absence of melanin pigment. The tumor cells showed cytoplasmic staining for HMB45, S100 and vimentin which confirmed the diagnosis of melanoma (Fig 4A-C) . The S100 is a sensitive, albeit not a specific, melanoma marker, decorating more than 95% of MM's of primary and metastatic sites. The diagnosis of MM requires confirmation with a melanocyte-specific marker, including HMB-45, Melan-A.
1 Although wilm's tumor, desmoplastic small round cell tumor, mesenchymal chondrosarcoma, small cell osteosarcoma and small cell carcinoma fall in the category of SMRCT, as we did not encounter these tumors during our study.
CONCLUSION
The SMRCTs are a heterogeneous group of malignant neoplasms. IHC represents a tool that can provide a clear distinction among the various tumor types. Its purpose is to categorize patients in order to ensure appropriate and specific treatment, as well as to identify tumors at higher risk of recurrence and fatal outcomes. Because IHC can provide such important information, it must be performed at a high standard so that the results are meaningful and reproducible. In recent years, a better understanding of molecular genetic 
